NfL’s time-dependent decrease in aging and Alzheimer’s disease is consistent with our observation of its development-associated increase and in support of NfL as a marker of neuronal integrity rather than neurodegeneration. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.